IJ Pharmaceutical Research
Mehdi Mohammadzadeh, Nazila Yousefi, Hesam Sharifinia© 2014 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Touwaide A. Exploring traditions. Iran J Pharm Res. 2022;4(2):e128218. doi: https://doi.org/10.22037/ijpr.2010.618
H. Shirazi F. Science and Scientists. Iran J Pharm Res. 2022;4(1):e128219. doi: https://doi.org/10.22037/ijpr.2010.609
Shafaati A. Chiral Drugs: Current Status of the Industry and the Market. Iran J Pharm Res. 2022;6(2):e128313. doi: https://doi.org/10.22037/ijpr.2010.702
Mojtahedzadeh M, Mahmoudi L. Aminoglycoside Resistance in ICUs: Are We Running out of Drugs, for Bad Bugs. Iran J Pharm Res. 2011;10(3):e125961. doi: https://doi.org/10.22037/ijpr.2011.956
Pourahmad J. The Need to Establish a Common Base Line for the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets. Iran J Pharm Res. 2022;7(4):e128597. doi: https://doi.org/10.22037/ijpr.2010.771
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
